DK1556488T3 - Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme - Google Patents

Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme

Info

Publication number
DK1556488T3
DK1556488T3 DK03758057T DK03758057T DK1556488T3 DK 1556488 T3 DK1556488 T3 DK 1556488T3 DK 03758057 T DK03758057 T DK 03758057T DK 03758057 T DK03758057 T DK 03758057T DK 1556488 T3 DK1556488 T3 DK 1556488T3
Authority
DK
Denmark
Prior art keywords
diseases
chondroosteomodulin
tig2
obesity
diagnosis
Prior art date
Application number
DK03758057T
Other languages
English (en)
Inventor
Wolfgang Meder
Martin Wendland
Harald John
Rudolf Richter
Markus Meyer
Wolf-Georg Forssmann
Original Assignee
Ipf Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipf Pharmaceuticals Gmbh filed Critical Ipf Pharmaceuticals Gmbh
Application granted granted Critical
Publication of DK1556488T3 publication Critical patent/DK1556488T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK03758057T 2002-10-31 2003-10-24 Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme DK1556488T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10251205 2002-10-31
PCT/EP2003/011799 WO2004039978A2 (de) 2002-10-31 2003-10-24 Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen

Publications (1)

Publication Number Publication Date
DK1556488T3 true DK1556488T3 (da) 2008-12-08

Family

ID=32185313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03758057T DK1556488T3 (da) 2002-10-31 2003-10-24 Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme

Country Status (7)

Country Link
US (1) US20060100145A1 (da)
EP (1) EP1556488B1 (da)
AT (1) ATE405648T1 (da)
AU (1) AU2003274076A1 (da)
DE (1) DE50310383D1 (da)
DK (1) DK1556488T3 (da)
WO (1) WO2004039978A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012323952A1 (en) * 2011-10-13 2014-04-24 Thomas Gadek Topical formulations of chemerin C15 peptides for the treatment of dermatological conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096299A1 (en) * 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof

Also Published As

Publication number Publication date
WO2004039978A2 (de) 2004-05-13
DE50310383D1 (de) 2008-10-02
EP1556488B1 (de) 2008-08-20
US20060100145A1 (en) 2006-05-11
AU2003274076A1 (en) 2004-05-25
WO2004039978A3 (de) 2004-07-22
EP1556488A2 (de) 2005-07-27
AU2003274076A8 (en) 2004-05-25
ATE405648T1 (de) 2008-09-15

Similar Documents

Publication Publication Date Title
BRPI0413728A (pt) muteìnas de lipocalina da lágrima
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
NO20080745L (no) Nye peptider for anvendelse i behandling av fedme
WO2006071778A3 (en) Treatment of parkinson's disease and related disorders using postpartum derived cells
DE50014411D1 (de) Medizinisches instrument zur abtragung von gewebe, knochenzement oder dergleichen im menschlichen oder tierischen körper
HK1062923A1 (en) Igf-binding protein-derived peptide
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
WO2005020928A3 (en) Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
ATE506961T1 (de) Ccn3 proteine zur behandlung und diagnose von nierenerkrankungen
MXPA05003818A (es) Perfilamiento de la expresion genica de muestras ffpe.
GB0617707D0 (en) A bone plate for fixation to a patient's vertebrae
NO20071238L (no) Fremgangsmater for leging av skader ved human IL-18 administrering
DK1556488T3 (da) Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme
CY1112440T1 (el) Απογλυκοζυλιωμενη και αποσιαλιδωμενη μακρα πεντραξινη ρτχ3
WO2003059248A3 (en) Pigment epithelium derived factor from human plasma and methods of use thereof
TW200741011A (en) Method for the diagnosis and treatment of cardiovascular diseases
ITBO20030261A1 (it) Unita'di irraggiamento luminoso per diagnosi e cura di problemi cutanei.
TNSN06147A1 (en) Use of cathepsin k inhibitors for treating of severe bone loss diseases
EA200600314A1 (ru) Использование растворимого cd164 при воспалительных и/или аутоимунных нарушениях
PL1612210T3 (pl) Nowe analogi nitrobenzylotioinozyny
RU2303413C2 (ru) Способ формирования фронтального отдела верхней челюсти, верхней губы, преддверия полости рта и твердого неба
WO2003097690A3 (en) Pth derivatives resistant to skin proteases
DE602005026705D1 (de) Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose